We also observed that these miRNAs achieved slightly higher AUC values in BRCAX breast tumors compared to BRCA1 and BRCA2 breast tumors, suggesting that these miRNAs have higher specificity and specificity rates for hereditary BRCAX as compared to BRCA1/2-mutated breast tumors. The gene discussed is BRCA2; the disease is breast neoplasm.